Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Talc is a mineral composed primarily of magnesium, silicon, and oxygen. In medicine, sterile pharmaceutical-grade talc is used as a sclerosing agent to prevent the recurrence of malignant pleural effusions in symptomatic patients. It is administered intrapleurally (into the chest cavity) during procedures such as thoracoscopy or open thoracotomy after fluid drainage to induce pleurodesis—the adhesion of the lung to the chest wall—thereby preventing further fluid accumulation. Talc acts by causing an inflammatory reaction that leads to fibrosis and obliteration of the pleural space. It is approved for this use in cancer patients with recurrent malignant pleural effusion[1][3][5][7]. Outside medicine, talc has widespread industrial and cosmetic applications. There have been concerns about potential health risks associated with non-medical uses of talcum powder[3][4]. The main approved indication is prevention of malignant pleural effusion recurrence; other uses are not established.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on talc.